questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Mécanismes moléculaires de l'action pharmacologique
Inhibiteurs de la synthèse d'acides gras
Inhibiteurs de la synthèse d'acides gras : Questions médicales fréquentes
Termes MeSH sélectionnés :
Early Detection of Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs de la synthèse d'acides gras : Questions médicales les plus fréquentes",
"headline": "Inhibiteurs de la synthèse d'acides gras : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Inhibiteurs de la synthèse d'acides gras : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-23",
"dateModified": "2025-02-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Inhibiteurs de la synthèse d'acides gras"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mécanismes moléculaires de l'action pharmacologique",
"url": "https://questionsmedicales.fr/mesh/D045504",
"about": {
"@type": "MedicalCondition",
"name": "Mécanismes moléculaires de l'action pharmacologique",
"code": {
"@type": "MedicalCode",
"code": "D045504",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.519"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs de la synthèse d'acides gras",
"alternateName": "Fatty Acid Synthesis Inhibitors",
"code": {
"@type": "MedicalCode",
"code": "D054872",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Wuyuan Zhang",
"url": "https://questionsmedicales.fr/author/Wuyuan%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "University of Chinese Academy of Sciences, Beijing, 100049, P. R. China."
}
},
{
"@type": "Person",
"name": "Anna Worthmann",
"url": "https://questionsmedicales.fr/author/Anna%20Worthmann",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany."
}
},
{
"@type": "Person",
"name": "Alexander W Fischer",
"url": "https://questionsmedicales.fr/author/Alexander%20W%20Fischer",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany."
}
},
{
"@type": "Person",
"name": "Klaus Tödter",
"url": "https://questionsmedicales.fr/author/Klaus%20T%C3%B6dter",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany."
}
},
{
"@type": "Person",
"name": "Clay F Semenkovich",
"url": "https://questionsmedicales.fr/author/Clay%20F%20Semenkovich",
"affiliation": {
"@type": "Organization",
"name": "Division of Endocrinology, Metabolism & Lipid Research, Department of Medicine, Washington University, St. Louis, MO, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37511475",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241411715"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.",
"datePublished": "2023-03-07",
"url": "https://questionsmedicales.fr/article/36894035",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.gastro.2023.02.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.",
"datePublished": "2023-02-28",
"url": "https://questionsmedicales.fr/article/36855007",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12350-023-03202-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Optimal age to stop prostate cancer screening and early detection.",
"datePublished": "2023-08-19",
"url": "https://questionsmedicales.fr/article/37598870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcpo.2023.100443"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.",
"datePublished": "2022-10-03",
"url": "https://questionsmedicales.fr/article/36121650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ijc.34298"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Mécanismes moléculaires de l'action pharmacologique",
"item": "https://questionsmedicales.fr/mesh/D045504"
},
{
"@type": "ListItem",
"position": 5,
"name": "Inhibiteurs de la synthèse d'acides gras",
"item": "https://questionsmedicales.fr/mesh/D054872"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Inhibiteurs de la synthèse d'acides gras - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Inhibiteurs de la synthèse d'acides gras",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Inhibiteurs de la synthèse d'acides gras",
"description": "Comment diagnostiquer une dyslipidémie ?\nQuels tests pour évaluer l'effet des inhibiteurs ?\nQuels symptômes indiquent un besoin d'inhibiteurs ?\nComment évaluer le risque cardiovasculaire ?\nQuels marqueurs biologiques sont pertinents ?",
"url": "https://questionsmedicales.fr/mesh/D054872?mesh_terms=Early+Detection+of+Cancer&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Inhibiteurs de la synthèse d'acides gras",
"description": "Quels symptômes d'une hyperlipidémie ?\nComment reconnaître une résistance à l'insuline ?\nQuels signes d'une maladie métabolique ?\nQuels symptômes d'une maladie cardiaque ?\nQuels symptômes d'une stéatose hépatique ?",
"url": "https://questionsmedicales.fr/mesh/D054872?mesh_terms=Early+Detection+of+Cancer&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Inhibiteurs de la synthèse d'acides gras",
"description": "Comment prévenir l'hyperlipidémie ?\nQuels exercices sont bénéfiques ?\nComment réduire le stress pour la santé ?\nQuel rôle joue l'hydratation ?\nComment éviter la sédentarité ?",
"url": "https://questionsmedicales.fr/mesh/D054872?mesh_terms=Early+Detection+of+Cancer&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Inhibiteurs de la synthèse d'acides gras",
"description": "Quels médicaments inhibent la synthèse des acides gras ?\nComment les inhibiteurs affectent-ils le métabolisme ?\nQuels sont les effets secondaires des inhibiteurs ?\nComment surveiller l'efficacité du traitement ?\nQuels changements de mode de vie sont recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D054872?mesh_terms=Early+Detection+of+Cancer&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Inhibiteurs de la synthèse d'acides gras",
"description": "Quelles complications peuvent survenir ?\nComment l'hyperlipidémie affecte-t-elle le foie ?\nQuels risques pour le système cardiovasculaire ?\nQuelles sont les conséquences d'une résistance à l'insuline ?\nComment l'obésité influence-t-elle la santé ?",
"url": "https://questionsmedicales.fr/mesh/D054872?mesh_terms=Early+Detection+of+Cancer&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Inhibiteurs de la synthèse d'acides gras",
"description": "Quels sont les principaux facteurs de risque ?\nQuel rôle joue l'hérédité ?\nComment l'âge affecte-t-il le risque ?\nQuel impact a le mode de vie sur la santé ?\nComment le stress influence-t-il la santé ?",
"url": "https://questionsmedicales.fr/mesh/D054872?mesh_terms=Early+Detection+of+Cancer&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dyslipidémie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un bilan lipidique sanguin permet de mesurer les niveaux de lipides et de déterminer la dyslipidémie."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'effet des inhibiteurs ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction hépatique et des dosages lipidiques sont effectués pour évaluer l'effet."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin d'inhibiteurs ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'hypercholestérolémie ou l'obésité peuvent indiquer un besoin d'inhibiteurs."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque cardiovasculaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque cardiovasculaire est évalué par des facteurs comme l'âge, le sexe, et les antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont pertinents ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de triglycérides et de cholestérol LDL sont des marqueurs importants à surveiller."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une hyperlipidémie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleurs abdominales et éruptions cutanées xanthomateuses."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une résistance à l'insuline ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'obésité abdominale et des niveaux élevés de glucose peuvent indiquer une résistance."
}
},
{
"@type": "Question",
"name": "Quels signes d'une maladie métabolique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une prise de poids inexpliquée, fatigue chronique et hypertension."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une maladie cardiaque ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure douleur thoracique, essoufflement et palpitations."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une stéatose hépatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleur dans le quadrant supérieur droit et jaunisse."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hyperlipidémie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine, riche en fibres et pauvre en graisses saturées, aide à prévenir l'hyperlipidémie."
}
},
{
"@type": "Question",
"name": "Quels exercices sont bénéfiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exercices aérobiques comme la marche, la course ou le vélo sont bénéfiques pour la santé cardiaque."
}
},
{
"@type": "Question",
"name": "Comment réduire le stress pour la santé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de gestion du stress comme la méditation et le yoga peuvent améliorer la santé globale."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'hydratation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hydratation est essentielle pour le métabolisme et la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Comment éviter la sédentarité ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Intégrer des pauses actives et des activités physiques régulières dans la routine quotidienne aide."
}
},
{
"@type": "Question",
"name": "Quels médicaments inhibent la synthèse des acides gras ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme l'acide acétylsalicylique et les statines inhibent la synthèse des acides gras."
}
},
{
"@type": "Question",
"name": "Comment les inhibiteurs affectent-ils le métabolisme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils réduisent la production d'acides gras, ce qui diminue les niveaux de lipides dans le sang."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des inhibiteurs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des troubles gastro-intestinaux et des douleurs musculaires."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des bilans lipidique et hépatique réguliers permettent de surveiller l'efficacité du traitement."
}
},
{
"@type": "Question",
"name": "Quels changements de mode de vie sont recommandés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et l'exercice régulier sont recommandés en complément des médicaments."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'athérosclérose et les maladies cardiaques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment l'hyperlipidémie affecte-t-elle le foie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hyperlipidémie peut entraîner une stéatose hépatique, affectant la fonction hépatique."
}
},
{
"@type": "Question",
"name": "Quels risques pour le système cardiovasculaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un excès d'acides gras peut augmenter le risque de maladies cardiovasculaires et d'accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une résistance à l'insuline ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La résistance à l'insuline peut mener au diabète de type 2 et à d'autres complications métaboliques."
}
},
{
"@type": "Question",
"name": "Comment l'obésité influence-t-elle la santé ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité augmente le risque de maladies métaboliques, cardiovasculaires et de certains cancers."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, le tabagisme, une alimentation riche en graisses et le manque d'exercice."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'hérédité ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hérédité peut influencer le métabolisme lipidique et le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Comment l'âge affecte-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de dyslipidémie et de maladies cardiovasculaires augmente avec l'âge."
}
},
{
"@type": "Question",
"name": "Quel impact a le mode de vie sur la santé ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et une mauvaise alimentation augmentent le risque de maladies métaboliques."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il la santé ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut contribuer à l'obésité et à des troubles métaboliques, augmentant les risques."
}
}
]
}
]
}
The central objective of the metamorphosis of discovery science into biomedical applications is to serve the purpose of patients and curtail the global disease burden. The journey from the discovery o...
Diagnosing gastric cancer (GC) while the disease remains eligible for surgical resection is challenging. In view of this clinical challenge, novel and robust biomarkers for early detection thus improv...
The present 3-step study incorporated data from 2141 patients, including 888 with GC, 158 with chronic atrophic gastritis, 193 with intestinal metaplasia, 501 healthy donors, and 401 with other gastro...
In discovery phase, one LR (GClnc1) was found to be up-regulated in both tissue and circulating EV samples with an area under the curve (AUC) of 0.9369 (95% confidence interval [CI], 0.9073-0.9664) fo...
EV-derived GClnc1 serves as a circulating biomarker for the early detection of GC, thus providing opportunities for curative surgery and improved survival outcomes....
Cancer therapy-induced cardiotoxicity is an emerging clinical and healthcare issue. Myocardial dysfunction and heart failure are mostly responsible for increased cardiovascular mortality in cancer dis...
Prostate Cancer screening should be discontinued at older ages because competing mortality risks eventually dominate the risk of Prostate Cancer and harms exceed benefits. We explored the Prostate Can...
We applied Bellman Equations to formulate the net benefits biopsy and "do nothing". Using difference between the net benefits of two alternatives, we calculated the stopping age. The cancer states wer...
Our results suggested that Prostate Cancer screening stopping ages from the patient, healthcare system, and social were 70, 68, and 68 respectively. The univariate sensitivity analysis showed that the...
Men should not be screened for Prostate Cancer beyond 70 years old, as this results in the net benefit of "do nothing" above the biopsy. Nevertheless, this finding needs to be further studied with mor...
Colorectal cancer (CRC) develops mainly from colorectal advanced adenomas (AA), which are considered precancerous lesions. Novel early diagnostic biomarkers are urgently needed to distinguish CRC and ...
The modality to detect ovarian cancer at an early stage is very limited. Early diagnosis determines the prognosis. This study aimed to develop a risk assessment tool for early detection of ovarian can...
This study was carried out as a cohort study of patients diagnosed with suspected ovarian tumors undergoing cytoreduction operation at Hasan Sadikin Hospital, Bandung, from December 2019 to September ...
In total, 115 patients included in this study. The differences were statistically significant in terms of the six variables (abdominal bloating, nausea/vomiting, decreased of appetite, fullness, menst...
Risk assessments based on ovarian cancer self-assessment unfortunately were not comparable to postoperative histopathology as a single predictor. Ten variables in ovarian cancer artificial intelligenc...
Early detection of colorectal cancer (CRC) significantly enhances patient outcomes. Conventional CRC screening tools, like endoscopy and stool-based tests, have constraints due to their invasiveness o...
In this research, we harnessed the Mutation Capsule Plus (MCP) technology to profile an array of genomic characteristics from cfDNA procured from a single blood draw. This profiling encompassed DNA me...
This model was subsequently validated in another cohort comprising 89 CRC patients and 95 healthy controls. Remarkably, the model achieved an area under the curve (AUC) of 0.981 (95% confidence interv...
Our findings underscore the clinical potential of our multiomics liquid biopsy test, indicating its prospective role as a noninvasive method for early-stage CRC detection. This multiomics approach hol...
Clinical diagnostics rely heavily on the detection and quantification of cancer biomarkers. The rapid detection of cancer-specific biomarkers is of great importance in the early diagnosis of cancers a...
A cell-free DNA (cfDNA) assay would be a promising approach to early cancer diagnosis, especially for patients with dense tissues. Consistent cfDNA signatures have been observed for many carcinogens. ...
Hepatocellular carcinoma (HCC) is the fastest-rising and fourth most common cause of cancer death worldwide. Liver cirrhosis is the largest underlying risk factor for HCC. Therefore, patients with cir...
This is a UK-based prospective, longitudinal, diagnostic, prognostic, multicentre, non-CTIMP study. Aiming to recruit 3000 patients with liver cirrhosis without a HCC diagnosis, the Pearl cohort will ...
Ethical approval has been granted by REC and the trial is registered on ClinicalTrials.gov. The results will be published in peer-reviewed journals and presented at relevant meetings....
NCT05541601....